Accession Mezzanine Capital III L.P., advised by Mezzanine Management, recently completed a growth capital investment, with total commitment of EUR 10 million, into BioVendor – Laboratorní Medicína a.s.
BioVendor is a Czech based enterprise primarily focusing on the in-vitro diagnostic (IVD) market and the biomedical research field. It specializes in the supply of equipment and consumables including its own range of IVD certified ELISA and immunoblot test kits. It also offers a range of unique immunoassays for the global research-use-only market.
Leave a Reply
You must be logged in to post a comment.